<< مقالات لاتين >>
<< بر اساس عنوان >>
1
History of the recognition of organic geochemistry in geoscience
2
History of the Representation of the DDC in the MARC Classification Format
3
History of the School of Public Health and Institute of Public Health Research of Tehran University
4
History of the search for continuous melting
5
History of the solar ponds: A review study
6
History of the South Java Current over the past 80 ka
7
History of the stiffness method
8
History of the treatment of childhood ALL: A paradigm for cancer cure
9
History of the Triumphs of Our Holy Faith Amongst the Most Barbarous and Fierce Peoples of the New World
10
History of the tuberous sclerosis complex
11
History of the West of Scotland Plastic Surgery Unit: 1940–1986
12
History of thymoma and yellow fever vaccination
13
History of torture
14
History of torture
15
History of treatments
16
History of Tropical Medicine: William Ernest Cooke, FRCSI (1879–1967) and his Asian tour of 1929–1930
17
History of tropospheric ozone for the San Bernardino Mountains of Southern California, 1963–1999
18
History of Tumescent Anesthesia, Part I: From American Surgical Textbooks of the 1920s and 1930s, ,
19
History of umbilical cord blood transplantation
20
History of upwelling in the Tropical Eastern Pacific and the paleogeography of the Isthmus of Panama
21
History of urinary tract infections and risk of renal cell carcinoma
22
History of water-column anoxia in the Black Sea indicated by pyrite framboid size distributions
23
History on Trial
24
History on Trial
25
History on Wikipedia: In need of a NWICO (New World Information and Communication Order)? the case of Cambodia
26
History plotting tool for Data Quality Monitoring
27
History plotting tool for Data Quality Monitoring
28
History recovery and source identification of multiple gaseous contaminants releasing with thermal effects in an indoor environment
29
History rediscovered: Welcome to 139 years of The Veterinary Journal
30
History repeating
31
History repeats itself: The failure of rational choice models in corporate governance
32
History Rewritten in a Postmodern Novel: Opposed Views on History in Jeanette Winterson’s The Passion
33
History Run Wild: The Alternate World of Joan Aiken’s The Wolves of Willoughby Chase Series
34
History through the eyes of the eyes
35
History versus expectations: Increasing returns or social influence?
36
History Writing That’s ‘‘Good to Think With’’: The Great Fire, Blizzard! and An American Plague
37
History, agency and political struggle: a different view
38
History, challenges and perspectives of cell microencapsulation
39
History, chemistry and biology of alkaloids from Lobelia inflata
40
History, collective memory and identity: the Tatars of sovereign Tatarstan
41
History, concept and spectrum of rheumatism, challenges in understanding
42
History, current state, and future of oil/gas industry in Russia. Academy of natural sciences of Russia, Moscow (1995)
43
History, current state, and future of oil/gas industry in Russia. Academy of natural sciences of Russia, Moscow (1995)
44
History, current state, and future of oil/gas industry in Russia. Academy of natural sciences of Russia, Moscow (1995)
45
History, current status, and collaborative research projects for Bemisia tabaci
46
History, distance and text: narratives of the 1853–1854 Perry expedition to Japan
47
History, meaning, and interpretation: a critical response to Bevir
48
History, memory, and justice: The Touvier trial in France
49
HISTORY, MORPHOLOGY AND PERFECT PROPORTIONS OF MUGHAL TOMBS: THE SECRET TO CREATION OF TAJ MAHAL
50
History, Narrative, and Photography in W. G. Sebalds Die Ausgewanderten
51
History, narrative, and time
52
History, opportunities and challenges for biological control in Australia, New Zealand and the Pacific islands
53
History, origin and extent of soil erosion on Easter Island (Rapa Nui)
54
HISTORY, POLITICS, AND CLAIMS OF MAN-MADE GLOBAL WARMING
55
History, principles, and practice of health and human rights
56
History, Structure and Agency in Global Health Governance; Comment on “Global Health Governance Challenges 2016 – Are We Ready?”
57
History, Studies and Specific Uses of Repetitive Transcranial Magnetic Stimulation (rTMS) in Treating Epilepsy
58
History, the kidney, and hypertension in blacks versus whites
59
History’s Worst Inventions and the People Who Made Them. Chaline, Eric. New Holland Publishers, UK, Ltd. (2009). £10.99, ISBN: 978 1 84773 505 8.
60
History-based price discrimination and entry in markets with switching costs: A welfare analysis
61
History-dependence of isometric muscle force: Effect of prior stretch or shortening amplitude
62
History-dependent magnetic properties in pure and Zn-doped cupric oxide
63
History-dependent modified sliding mode interception strategies with maximal capture zone
64
History-dependent phase slips and rectification of a few coupled oscillators system
65
History-sensitive versus future-sensitive approaches to security in distributed systems
66
History-taking and Preventive Medicine Skills among Primary Care Physicians: An Assessment Using Standardized Patients
67
Histpathological Anti-inflammatory Effects of Flunixin Meglumine and Ketoprofen on Excised Rat Tendon
68
His–Trp cation–π interaction and its structural role in an α-helical dimer of HIV-1 Vpr protein Original Research Article
69
Hit and target models for DNA damage with indirect action
70
Hit covariance formalism for stereo detectors
71
Hit covariance formalism for stereo detectors
72
Hit diabetes hard and early for best long-term results
73
Hit efficiency study of CMS prototype forward pixel detectors
74
Hit efficiency study of CMS prototype forward pixel detectors
75
Hit ʹEm Where They Live: Targeting the Cancer Stem Cell Niche
76
Hit generation and exploration: Imidazo[4,5-b]pyridine derivatives as inhibitors of Aurora kinases
77
Hit harder than HAART
78
Hit HIV-1 hard, but only when necessary Review Article
79
HIT in VAD Patients: Considerations
80
Hit or miss: branch structure affects perch choice, behaviour, distance and accuracy of brown tree snakes bridging gaps
81
Hit statistics in FH-CDMA unslotted packet networks
82
Hitachi Hemolytic Index correlates with HBOC-201 concentrations: Impact on suppression of analyte results
83
Hitch in implementing Russiaʹs HIV-prevention law
84
Hitch in US product-liability reform for pharmaceuticals
85
Hitches in implementing organ-donation law in Poland
86
Hitchhikers on the fungal highway: The helper effect for bacterial migration via fungal hyphae
87
Hitchhikers on the fungal highway: The helper effect for bacterial migration via fungal hyphae
88
Hitchhiking without Covalent Integration
89
Hitching a ride on a hermit crabs home: Movement of gastropod shells inhabited by hermit crabs
90
Hitchin–Thorpe inequality for noncompact Einstein 4-manifolds
91
Hi-tech breast-cancer screening: will it deliver?
92
hITeQ: A new workflow-based computing environment for streamlining discovery. Application in materials science
93
HIT-IIP: an information integrating platform for CIM system based on client/server architecture
94
Hitler, the Germans, and the Final Solution. By Ian Kershaw. New Haven, CT, and London: Yale University Press. 2008.
95
Hitler’s Ethic: The Nazi Pursuit of Evolutionary Progress. By Richard Weikart. New York: Palgrave Macmillan. 2009
96
Hitler’s Generals on Trial: The Last War Crimes Tribunal at Nuremberg. By Valerie Geneviève Hébert. Lawrence, KS: University Press of Kansas. 2010
97
Hitler’s Man in Havana: Heinz Lu¨ning and Nazi Espionage in Latin America. By Thomas D. Schoonover. With a Foreword by Louis A. Perez, Jr. Lexington, KY: University of Kentucky Press. 2008.
98
Hitlers Judenhass. Klischee und Wirklichkeit. By Ralf Georg Reuth. Munich: Piper Verlag. 2009
99
Hitologic and clinical evaluation of combined eyelid erbium:YAG and CO2 laer reurfacing
100
Hitologic Correlation of In Vivo Optical Coherence Tomography Image of the Human Retina
101
Hitologic parameter helpful to recognize teroid-treated temporal arteriti: An analyi of thirty-five cae
102
Hitologic tudy of retiniti pigmentoa due to a mutation in the RP13 gene (PRPC8): comparion with rhodopin Pro23Hi, Cy110Arg, and Glu181Ly
103
Hitology of the vitreoretinal interface after taining of the internal limiting membrane uing glucoe 5% diluted indocyanine and infracyanine green
104
Hitopathologic analyi of 232 eye with retinoblatoma conducted in an Indian tertiary-care ophthalmic center
105
Hitopathologic and immunohitochemical tudy of dominant cone degeneration
106
Hitopathologic and Immunologic Apect of AlphaCor Artificial Corneal Failure Original Reearch Article
107
Hitopathologic characteritic of uveal melanoma in eye enucleated from the collaborative ocular melanoma tudy COM report no. 6 Original Reearch Article
108
Hitopathologic Examination of Conjunctival Tophi in Gouty Arthriti
109
Hitopathologic Finding After Radial Optic Neurotomy in Central Retinal Vein Occluion
110
Hitopathologic tudy of variation in everity of retiniti pigmentoa due to the dominant rhodopin mutation Pro23Hi
111
Hitopathologic tudy of X-linked cone-rod dytrophy (CORDX1) caued by a mutation in the RPGR exon ORF15
112
Hitopathological abnormalitie in ocular blood veel of CADAIL patient
113
Hitopathology of Blepharoptoi Induced by Prolonged Hard Contact Len Wear
114
Hitopathology of the eye in diffue neonatal hemangiomatoi
115
Hitoshi Oshitani: watching out for an influenza pandemic
116
Hitoshi Sakai (1930–2008)
117
Hitox titanium pigment prices raised
118
Hitox titanium pigment prices raised for the second time this year
119
Hits and flops dynamics
120
Hits and misses: crafting a pop single for the top-40 market in the 1960s
121
Hits-and-misses for the evaluation and combination of forecasts
122
Hitting a Nerve: Ion Channels May Hold the Key for Treating Chronic Pain
123
Hitting and returning to rare events for all alpha-mixing processes
124
Hitting from any direction in 3-D space by a robot with a flexible link hammer
125
Hitting H pylori for four
126
Hitting HIV where it hurts: an alternative approach to HIV vaccine design
127
Hitting moving targets: Co-operative control of ‘when’ and ‘where’
128
Hitting of a line or a half-line in the plane by two-dimensional symmetric stable Lévy processes
129
Hitting probabilities and hitting times for stochastic fluid flows
130
HITTING PROBABILITIES AND HITTING TIMES FOR STOCHASTIC FLUID FLOWS THE BOUNDED MODEL
131
Hitting probabilities for non-convex lattice
132
Hitting sets when the VC-dimension is small
133
Hitting Spheres with Brownian Motion and Sommerfeld′s Radiation Condition
134
Hitting the distributed computing sweet spot with Tspaces
135
Hitting the mark or falling short with nanotechnology regulation? Original Research Article
136
Hitting the Target with Bifunctional Phage Review Article
137
Hitting time analysis for a class of random packet forwarding schemes in ad hoc networks
138
Hitting time distributions in financial markets
139
Hitting times for the perturbed reflecting random walk
140
Hitting times of Brownian motion and the Matsumoto–Yor property on trees
141
Hit-to-lead optimization of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of KDR kinase inhibitors
142
Hit-to-lead studies on benzimidazole inhibitors of ITK: Discovery of a novel class of kinase inhibitors
143
Hit-to-Lead studies: The discovery of potent adamantane amide P2X7 receptor antagonists
144
Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors
145
Hit-to-Lead studies: The discovery of potent, orally bioavailable thiazolopyrimidine CXCR2 receptor antagonists
146
Hit-to-Lead studies: The discovery of potent, orally bioavailable triazolethiol CXCR2 receptor antagonists
147
HIV “escape” mutants could thwart vaccine development
148
HIV A clever hijacker of the immune system
149
HIV and AIDS among the Severely Mentally Ill: Introduction to the special series
150
HIV and AIDS in southeast Asia
151
HIV and AIDS, poverty, and causation
152
HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action
153
HIV and autoimmunity
154
HIV and bone disease
155
HIV and cancer of the cervix
156
HIV and Cardiovascular Disease in Sub-Saharan Africa: The Sutton Law as Applied to Global Health
157
HIV and communication
158
HIV and complement: hijacking an immune defense
159
HIV and Coronary Heart Disease: Time for a Better Understanding
160
HIV and depression: context and care: Francisco J. Gonzales; UCSF AIDS Health Project, San Francisco, 2001, 106pp, $11.95 (paper)
161
HIV and diarrhea in the era of HAART: 1998 New York State hospitalizations
162
HIV and exclusive breastfeeding: Just how exclusive and when to stop?
163
HIV and gynaecological infections
164
HIV and hepatitis C virus RNA in seronegative organ and tissue donors
165
HIV and human rights in refugee settings
166
HIV and intimate partner violence among methadone-maintained women in New York City
167
HIV and Islam: is HIV prevalence lower among Muslims?
168
HIV and orientation of subsistence and commercial home gardens in rural Ghana: Crop composition, crop diversity and food security
169
HIV and peacekeeping operations in Cambodia
170
HIV and primary health care: disclosure and discrimination
171
HIV and sexual health in the UK: politics and public health
172
HIV and the blood supply: An analysis of crisis decisionmaking : Edited by Lauren B. Leveton, Harold C. Sox Jr, and Michael A. Stoto. Institute of Medicine, National Academy Press, Washington, DC, 1995. 352 pp., $47.95 (cloth)
173
HIV and the cell cycle
174
HIV and the paediatrician as the childʹs advocate
175
HIV and tuberculosis in the former Soviet Union
176
HIV as the cause of AIDS
177
HIV case shocks USA
178
HIV causes AIDS: Kochʹs postulates fulfilled
179
HIV clearance in infants
180
HIV co-infection with a currently non-pathogenic flagellate
181
HIV control in Cuba
182
HIV control in vivo: Dynamical analysis
183
HIV controllers: A multifactorial phenotype of spontaneous viral suppression
184
HIV co-receptor identification: good or bad news for drug discovery?
185
HIV Coreceptor Usage and Drug Treatment
186
HIV could blunt progress in China, Clinton warns
187
HIV disclosure and discussions about grief with Shona children: A comparison between health care workers and community members in Eastern Zimbabwe
188
HIV Disclosure by Perinatal Women in Thailand
189
HIV discoverers awarded Nobel Prize for medicine
190
HIV Disease
191
HIV disease in the year 2000
192
HIV disease progression and effects of tuberculosis preventive therapy in HIV-infected adults
193
HIV disease progression: depression, stress, and possible mechanisms
194
HIV disease treatment in the era of HAART
195
HIV disease: mucocutaneous fungal infections in HIV disease
196
HIV dynamics: Analysis and robust multirate MPC-based treatment schedules
197
HIV dynamics: Modeling, data analysis, and optimal treatment protocols
198
HIV education for health-care professionals in high prevalence countries: time to integrate a pre-service approach into training
199
HIV Enters Cells via Endocytosis and Dynamin-Dependent Fusion with Endosomes
200
HIV entry inhibitors
201
HIV Entry Revisited
202
HIV Envelope-CXCR4 Signaling Activates Cofilin to Overcome Cortical Actin Restriction in Resting CD4 T Cells
203
HIV epidemic could number 40 million by year 2000
204
HIV epidemic in Central India: trends over 18 years (1986–2003)
205
HIV epidemic in India
206
HIV epidemic in India: opportunity to learn from the past
207
HIV epidemic in Russia
208
HIV escape from cytotoxic T lymphocytes: a potential hurdle for vaccines?
209
HIV Fusion Peptide Penetrates, Disorders, and Softens T-Cell Membrane Mimics
210
HIV Gag p24 specific responses secreting IFN-γ and/or IL-2 in treatment-naïve individuals in acute infection early disease (AIED) are associated with low viral load
211
HIV gene arrests cell cycle
212
HIV Genetic effects on immunity Immunity to infection Web alert
213
HIV gp120 V1/V2 and C2-V3 domains glycoprotein compatibility is required for viral replication
214
HIV gp120: double lock strategy foils host defences
215
HIV in central and eastern Europe
216
HIV in England and Wales
217
HIV in the over-50s in south London
218
HIV incidence among injecting drug users in New York City syringe-exchange programmes
219
HIV Incidence and CDC’s HIV Prevention Budget: An Exploratory Correlational Analysis
220
HIV infection and advanced age: Emerging epidemiological, clinical, and management issues
221
HIV infection and chronic hepatitis C
222
HIV infection and high density lipoprotein metabolism
223
HIV infection and high-risk behaviors in opioid dependent patients: The Indian context
224
HIV infection and neoplasia
225
HIV infection and neoplasia
226
HIV infection and neoplasia
227
HIV infection and neoplasia
228
HIV infection and neoplasia
229
HIV Infection and the Dynamic Interplay between the Thymus and the Peripheral T Cell Pool
230
HIV infection from donor semen
231
HIV infection in Cuban women
232
HIV infection of CD8 cells
233
Hiv infection of endothelial cells promotes the development of aids-associated b cell lymphomas
234
HIV infection of mononuclear cells is calcium-dependent
235
HIV infection rates in Japan projected to increase
236
HIV infection reduces skin graft survival in burn injuries: a prospective study
237
HIV infection: first battle decides the war
238
HIV infection: where have all the T cells gone?
239
HIV interaction with endosomes in macrophages and dendritic cells
240
HIV levels in motherʹs blood predicts risk of perinatal transmission
241
HIV levels may predict mother-to-child
242
HIV may produce inhibitory microRNAs (miRNAs) that block production of CD28, CD4 and some interleukins
243
HIV Modes of Transmission in Sudan in 2014
244
HIV myths should not be resuscitated
245
HIV myths should not be resuscitated
246
HIV myths should not be resuscitated – Authorʹs reply
247
HIV nucleoside analogues: new adverse effects on mitochondria?
248
HIV outreach for hard-to-reach populations: a cross-site perspective
249
HIV overshadows South African health advances
250
HIV p17 reverses the anti-inflammatory activity of IL-4 on IL-15 stimulated monocytes and modulates their ability to secrete MIP-1 alpha
251
HIV positive women's living experiences
252
HIV postexposure prophylaxis for children and adolescents
253
HIV postexposure prophylaxis in the emergency department: The morning after is today
254
HIV Postexposure Prophylaxis in Victims of Child Sexual Abuse
255
HIV postexposure prophylaxis practices by US ED practitioners
256
HIV Preparing for HIV vaccines that induce cytotoxic T lymphocytes
257
HIV prevalence among pregnant women in Kigali, Rwanda
258
HIV prevalence and poverty in Africa: Micro- and macro-econometric evidences applied to Burkina Faso
259
HIV Prevalence and Risk Behaviors among Patients Attending Los Angeles County Tuberculosis Clinics: 1993–1996
260
HIV prevalence and trends in sub-Saharan Africa: no decline and large subregional differences
261
HIV prevention among Zambian adolescents: Developing a value utilization/norm change model
262
HIV prevention and treatment in South Africa: affordable and desirable
263
HIV prevention before HAART in sub-Saharan Africa
264
HIV prevention efforts reach fewer than one in five at risk
265
HIV prevention for intravenous drug users
266
HIV prevention in developed countrie
267
HIV prevention research in a resource-limited setting: the experience of planning a trial in Cambodia
268
HIV prevention research: the ecstasy and the agony
269
HIV prevention, childrens rights, and homosexual youth
270
HIV programme for aid workers in Norway
271
HIV protease inhibitor HOE/BAY 793, structure-activity relationships in a series of C2-symmetric diols Original Research Article
272
HIV protease inhibitor Lopinavir induces apoptosis of primary effusion lymphoma cells via suppression of NF-κB pathway
273
HIV protease inhibitors block oral epithelial cell DNA synthesis
274
HIV protease inhibitors have specific anti-cancer effects
275
HIV protease inhibitors increase TNF-α and IL-6 expression in macrophages: Involvement of the RNA-binding protein HuR
276
HIV protease inhibitors with picomolar potency against PI-Resistant HIV-1 by extension of the P3 substituent
277
HIV quantification: clinical applications
278
HIV quantification: useful for prediction of vertical transmission?
279
HIV Rapid Diagnostic Test Inventories in Zambézia Province, Mozambique: A Tale of 2 Test Kits
280
HIV Recent advances in AIDS research: genetics, molecular biology and immunology
281
HIV research: a need to focus on the right target
282
HIV Responses in Arab States on the Southern Persian Gulf Border: The First Review
283
HIV Rev self-assembly is linked to a molten-globule to compact structural transition Original Research Article
284
HIV risk behavior among adults with severe mental illness: A systematic review
285
Hiv risk behavior among alcoholic inpatients before and after treatment
286
HIV risk environment for Ghanaian women: challenges to prevention
287
HIV risk networks and HIV transmission among injecting drug users
288
HIV risk reduction among injection drug users: explaining the lack of anticipated outcomes in a community-level controlled comparison study
289
HIV risk reduction for the seriously mentally ill: Pilot investigation and call for research
290
HIV risk reduction interventions for persons with severe mental illness
291
HIV risk-reduction in adolescents
292
HIV risks among homeless men differentiated by cocaine use and psychiatric distress
293
HIV risks in incarcerated injection-drug users
294
HIV screening of blood transfusions in Zambia
295
HIV self-testing: a time to revise current policy
296
HIV Seroprevalence among Newly Incarcerated Inmates in the Texas Correctional System
297
HIV seroprevalence among people with severe mental illness in the United States: A critical review
298
HIV seroprevalence by anonymous testing in patients with Mycobacterium tuberculosis and in tuberculosis contacts
299
HIV serostatus and factors related to physical and mental well-being in Latina family AIDS caregivers
300
HIV status disclosure and partner discordance: A public health dilemma
301
HIV stigma: perceptions from HIV-positive and HIV-negative patients in a community dental clinic
302
HIV strategically targets HIV-specific T cells
303
HIV superinfection: another reason to avoid serosorting practice
304
HIV test results, partner notification, and personal conduct
305
HIV Testing among Men Who Have Sex with Men—Results of a Telephone Survey
306
HIV testing and human rights
307
HIV testing history among gay/bisexual men recruited in Barcelona: Evidence of high levels of risk behavior among self-reported HIV+ men
308
HIV testing in developing countries
309
HIV testing in prison
310
HIV Testing in the Emergency Department: Pretest Counseling or Pretest Education?
311
HIV testing over Easter
312
HIV testing: Should the emergency department take part?
313
HIV testing: the mutual rights and responsibilities of partners
314
HIV tests for babies to be mandatory in USA
315
HIV The immune response
316
HIV time hierarchy: winning the war while, loosing all the battles
317
HIV transmission by donor semen
318
HIV transmission by transplantation of allograft skin: a review of the literature
319
HIV transmission from surrogate breastfeeding
320
HIV transmission through health care in sub-Saharan Africa
321
HIV transmission through health care in sub-Saharan Africa
322
HIV transmission through health care in sub-Saharan Africa
323
HIV transmission under highly active antiretroviral therapy
324
HIV transmission under highly active antiretroviral therapy – Authorsʹ reply
325
HIV treatment in South Africa: overcoming impediments to get started
326
HIV treatment in South African children
327
HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis
328
HIV treatment, injection drug use, and illicit drug policies
329
HIV vaccine fails in phase 3 trial
330
HIV vaccine: how long must we wait?
331
HIV vaccine: how long must we wait?
332
HIV vaccines: where we are and where we are going
333
HIV voluntary counselling and testing in community health services
334
HIV, confidentiality, gender, and support in rural South Africa
335
HIV, EBV and KSHV: Viral cooperation in the pathogenesis of human malignancies
336
HIV, fatal rotavirus infection, and treatment options
337
HIV, fatal rotavirus infection, and treatment options
338
HIV, occupational exposure, and medical responsibilities
339
HIV/AIDS Among Injecting Drug Users: A review on Epidemiology and Management of Occupational Exposure in Iranian Health Network Setting
340
HIV/AIDS and access to water: A case study of home-based care in Ngamiland, Botswana
341
HIV/AIDS and community conflict in Nigeria: implications and challenges
342
HIV/AIDS and Education: a study on how a selection of school governing bodies in Mpumalanga understand, respond to and implement legislation and policies on HIV/AIDS
343
HIV/AIDS and human rights
344
HIV/AIDS and its impact on student nurses
345
HIV/AIDS and people with disability
346
HIV/AIDS and the construction of Sub-Saharan Africa: Heuristic lessons from the social sciences for policy
347
HIV/AIDS cases in 1999 set to keep increasing into the next century
348
HIV/AIDS conference highlights Lesothoʹs progress
349
HIV/AIDS control in India
350
HIV/AIDS Counseling Skills and Strategies: Can Testing and Counseling Curb the Epidemic?
351
HIV/AIDS data in South Africa
352
HIV/AIDS data in South Africa
353
HIV/AIDS Disease: Transmission Transition
354
HIV/AIDS dynamics: Impact of economic classes with transmission from poor clinical settings
355
HIV/AIDS education among incarcerated youth
356
HIV/AIDS epidemiology
357
HIV/AIDS epidemiology, pathogenesis, prevention, and treatment
358
HIV/AIDS estimates and the quest for universal access
359
HIV/AIDS explosion in Russia triggers research boom
360
HIV/AIDS Good News and Bad News
361
HIV/AIDS harm reduction in Iran
362
HIV/AIDS High Risk Behaviors and Necessity of Prevention in the Population of Birjand, East of Iran 2013 to 2014: A Population-Based Study
363
HIV/AIDS in Africa
364
HIV/AIDS IN AFRICA IN CONTEXT
365
HIV/AIDS in Africa, 2002
366
HIV/AIDS in Asia
367
HIV/AIDS in children: a disaster in the making
368
HIV/AIDS in China: the numbers problem
369
HIV/AIDS in South Africa
370
HIV/AIDS infection control enforcement: a comparison between Nigeria and the United States
371
HIV/AIDS Information Awareness among Market Women: A Study of Olofimuyin Market, Sango-Ota, Ogun State, Nigeria
372
HIV/AIDS information outreach: a community-based approach
373
HIV/AIDS information overload
374
HIV/AIDS institutional discrimination in Switzerland
375
HIV/AIDS issues take centre-stage at World Health Assembly
376
HIV/AIDS Knowledge and Attitude among High School Students in Shiraz, Iran in 2015
377
HIV/AIDS Knowledge and attitudes of Southern Iranian students
378
HIV/AIDS lowers UNʹs global population estimates
379
HIV/AIDS policy agenda setting in Iran
380
HIV/AIDS prevention and treatment
381
HIV/AIDS prevention and treatment
382
HIV/AIDS prevention and treatment
383
HIV/AIDS prevention and treatment
384
HIV/AIDS prevention and treatment
385
HIV/AIDS prevention and treatment
386
HIV/AIDS prevention for migrants and ethnic minorities: three phases of evaluation
387
HIV/AIDS Related Stigma in Iran: A Qualitative Study
388
HIV/AIDS research in India: A bibliometric study
389
HIV/AIDS Risk Behaviours Among Injecting Drug Users: Addressing Development of Risk Behaviour Knowledge and Patterns of Risk Behaviour Practices in Context of Demographic Characteristics
390
HIV/AIDS Situation in Economic Cooperation Countries; Achievement and Gaps toward Millennium Development Goals
391
HIV/AIDS treatment and HIV vaccines for Africa
392
HIV/AIDS vulnerability of Nepali migrants to India: whose concern?
393
HIV/AIDS, artisanal fishing and food security in the Okavango Delta, Botswana
394
HIV/AIDS, gender, agency and empowerment issues in Africa
395
HIV/AIDS, human capital, and economic growth prospects for Mozambique
396
HIV/AIDS. A Guide to Nursing Care, 3rd edn., J.H. Flaskerud, P. Unguarski. W B Saunders, Switzerland (1995), ISBN: 0 7216 5239 5
397
HIV/AIDS: A Cross-cutting Theme in Human Rights –Domestic and International Dimensions
398
HIV/AIDS: Global Frontiers in Prevention/Intervention, C. Pope, R.T. White, R. Malow (Eds.). Routledge, New York (2008). 572 p., paperback US$49.95, ISBN: 978-0-415-95383-2.
399
HIV/AIDS: in search of an animal model Original Research Article
400
HIV/AIDS: the private sector is vital
401
HIV/AIDS—An issuein nurse education
402
HIV/AIDS-Associated Stigma Among Afro-Caribbean People Living in the United States
403
HIV/AIDS—call for papers
404
HIV/AIDS—call for papers
405
HIV/AIDS-related social anxieties in adolescents in three African countries
406
HIV/AIDS-related stigma and discrimination: Accounts of HIV-positive Caribbean people in the United Kingdom
407
HIV/HBV Co-Infections: Epidemiology, Natural History, and Treatment: A Review Article
408
HIV/HCV coinfection, HAART, and liver-related mortality
409
HIV/HCV coinfection, HAART, and liver-related mortality
410
HIV/STD-Protective Benefits of Living with Mothers in Perceived Supportive Families: A Study of High-Risk African American Female Teens
411
HIV: An Epidemiologic study on Head and Neck Involvement in 50 Patients
412
HIV: Immunity to infection. Genetic effects on immunity: Web alert
413
HIV: Medical Milestones and Clinical Challenges
414
HIV: Pre-exposure Prophylaxis
415
HIV: T cell responses to HIV: Editorial overview
416
HIV: the other dimension
417
HIV: Ufff…I Got a Needle Prick
418
HIV-1 and AIDS awareness in a marginalised Namibian community
419
HIV-1 and hepatitis B virus: time for a re-think?
420
HIV-1 and immune control: can we change the course of HIV-1?
421
HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers
422
HIV-1 and scrub-typhus
423
HIV-1 and tuberculosis infection
424
HIV-1 and tuberculosis infection
425
HIV-1 at 25
426
HIV-1 biological phenotype and predicted coreceptor usage based on V3 loop sequence in paired PBMC and plasma samples
427
HIV-1 care in resource-poor settings: a view from Haiti
428
HIV-1 Coreceptor Selectivity: Structural Analogy between HIV-1 V3 Regions and Chemokine β-Hairpins Is Not the Explanation
429
HIV-1 disease progression and AIDS-defining disorders in rural Uganda
430
HIV-1 diversity versus HLA class I polymorphism
431
HIV-1 DNA vaccine shows promise in chimpanzees
432
HIV-1 drug resistance reported in Brazil
433
HIV–1 dynamics at different time scales under antiretroviral therapy
434
HIV-1 Envelope Glycoprotein Biosynthesis, Trafficking, and Incorporation Review Article
435
HIV-1 fusion mechanism could be target for new drugs
436
HIV-1 Gag Extension: Conformational Changes Require Simultaneous Interaction with Membrane and Nucleic Acid
437
HIV-1 Genome Nuclear Import Is Mediated by a Central DNA Flap
438
HIV-1 gp120-induced sickness behavior is exacerbated in aged mice: Is this exaggerated sickness behavior potentially mediated through a pathway involving the up-regulation of CXCR4?
439
HIV-1 group O and group M dual infection in Bénin
440
HIV-1 group O and group M dual infection in Bénin
441
HIV-1 group O infection identified in USA
442
HIV-1 group O infection in the USA
443
HIV-1 immunopathogenesis: How good interferon turns bad
444
HIV-1 in injecting-drug users and heterosexuals
445
HIV-1 in semen: an isolated virus reservoir
446
HIV-1 in Taiwan
447
HIV-1 incidence and prevalence trends in Uganda
448
HIV-1 incidence and prevalence trends in Uganda
449
HIV-1 incidence in sub-Saharan Africa
450
HIV-1 induced decrease of nitric oxide production and inducible nitric oxide synthase expression during in vivo and in vitro infection
451
HIV-1 infected patients with toxic epidermal necrolysis: an occupational risk for healthcare workers
452
HIV-1 infection and intraepithelial neoplasia of lower genital tract
453
HIV-1 infection and malaria parasitaemia
454
HIV-1 infection and malaria parasitaemia
455
HIV-1 infection and malaria parasitaemia
456
HIV-1 infection and malaria parasitaemia
457
HIV-1 infection and prostitutes
458
HIV-1 infection and risk of tuberculosis after rifampicin treatment
459
HIV-1 infection and risk of tuberculosis after rifampicin treatment
460
HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study
461
HIV-1 infection and the female genital tract
462
HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis
463
HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis
464
HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis
465
HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis
466
HIV-1 infection by artificial insemination
467
HIV-1 infection in a man homozygous for CCR5▭∆32
468
HIV-1 infection in an individual homozygous for CCR5▭∆32
469
HIV-1 infection in China
470
HIV-1 infection in commercial plasma donors in China
471
HIV-1 infection in foreign nationals working in East Timor
472
HIV-1 Infection Induces Acetylation of NPM1 That Facilitates Tat Localization and Enhances Viral Transactivation
473
HIV-1 infection initiates changes in the expression of a wide array of genes in U937 promonocytes and HUT78 T cells
474
HIV-1 infection kinetics in tissue cultures
475
HIV-1 infection puzzles Denmark
476
HIV-1 infection rapidly alters cell gene expression
477
HIV-1 integrase pharmacophore model derived from diverse classes of inhibitors
478
HIV-1 Integrase Strand Transfer Inhibitors Stabilize an Integrase–Single Blunt-Ended DNA Complex
479
HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots
480
HIV-1 long terminal repeat modulation by glucocorticoids in monocytic and lymphocytic cell lines
481
HIV-1 Matrix Protein Binding to RNA
482
HIV-1 matrix protein: A mysterious regulator of the viral life cycle
483
HIV-1 Nef associates with p22-phox, a component of the NADPH oxidase protein complex
484
HIV-1 Nef Dimerization Is Required for Nef-Mediated Receptor Downregulation and Viral Replication
485
HIV-1 Nef Downregulates MHC-I by a PACS-1- and PI3K-Regulated ARF6 Endocytic Pathway
486
HIV-1 nucleocapsid protein activates transient melting of least stable parts of the secondary structure of TAR and its complementary sequence
487
HIV-1 Nucleocapsid Protein as a Nucleic Acid Chaperone: Spectroscopic Study of its Helix-destabilizing Properties, Structural Binding Specificity, and Annealing Activity
488
HIV-1 Nucleocapsid Protein Binds to the Viral DNA Initiation Sequences and Chaperones their Kissing Interactions
489
HIV-1 Nucleocapsid Protein Switches the Pathway of Transactivation Response Element RNA/DNA Annealing from Loop–Loop “Kissing” to “Zipper”
490
HIV-1 nucleocapsid protein zinc finger structures induce tRNALys,3 structural changes but are not critical for primer/template annealing
491
HIV-1 p17 binds heparan sulfate proteoglycans to activated CD4+ T cells
492
HIV-1 peripheral neuropathy and combination antiretroviral therapy
493
HIV-1 prevalence in young adults in south India
494
HIV-1 prevalence in young adults in south India
495
HIV-1 prevalence in young adults in south India
496
HIV-1 prevalence in young adults in south India
497
HIV-1 prevalence in young adults in south India
498
HIV-1 prevalence in young adults in south India – Authorsʹ reply
499
HIV-1 prevention in the context of increasing access to treatment
500
HIV-1 progression in hepatitis-C-infected drug users
501
HIV-1 progression in hepatitis-C-infected drug users
502
HIV-1 progression in hepatitis-C-infected drug users
503
HIV-1 progression in hepatitis-C-infected drug users
504
HIV-1 Protease Dimer Interface Mutations that Compensate for Viral Reverse Transcriptase Instability in Infectious Virions
505
HIV-1 protease inhibitors containing an N-Hydroxyamino acid core structure Original Research Article
506
HIV-1 protease inhibitors with picomolar potency against PI-resistant HIV-1 by modification of the P1′ substituent
507
HIV-1 Proteinase as Structural Model of Intercellular Transport Proteins of Plant Viruses
508
HIV-1 reactivation in HIV-latently infected dendritic cells by oral microorganisms and LPS
509
HIV-1 Replication and Latency Are Regulated by Translational Control of Cyclin T1
510
HIV-1 Replication in Monocyte-derived Dendritic Cells is Stimulated by Melarsoprol, One of the Main Drugs Against Human African Trypanosomiasis
511
HIV-1 replication in patients with undetectable plasma virus receiving HAART
512
HIV-1 replication inhibitors of the styrylquinoline class: incorporation of a masked diketo acid pharmacophore
513
HIV-1 replication inhibitors of the styrylquinoline class: introduction of an additional carboxyl group at the C-5 position of the quinoline
514
HIV-1 researchers talk cautiously of a good year
515
HIV-1 Reverse Transcriptase Can Simultaneously Engage Its DNA/RNA Substrate at Both DNA Polymerase and RNase H Active Sites: Implications for RNase H Inhibition
516
HIV-1 Reverse Transcriptase Dissociates during Strand Transfer
517
HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: A view from the clinic and ex vivo
518
HIV-1 reverse transcription initiation: A potential target for novel antivirals?
519
HIV-1 Reverse Transcription: A Brief Overview Focused on Structure–Function Relationships among Molecules Involved in Initiation of the Reaction
520
HIV-1 RNA and CD4+ counts to predict the risk of AIDS
521
HIV-1 RNA serum-load and resistant viral genotypes during early zidovudine therapy
522
HIV-1 Sequence Variation: Drift, Shift, and Attenuation
523
HIV-1 seroprevalence rates in women and relinquishment of infants to the state in St Petersburg, Russia, 2002
524
HIV-1 serum RNA load and resistance during early ZDV therapy
525
HIV-1 shedding in genital tract of infected women
526
HIV-1 shedding in genital tract of infected women
527
HIV-1 shedding in genital tract of infected women
528
HIV-1 specific CD8+ T cells with an effector phenotype and control of viral replication
529
HIV-1 statistics bring good news for Uganda
530
HIV-1 subtype B in Honduras
531
HIV-1 subtype B in West Africa
532
HIV-1 subtype C in China
533
HIV-1 subtypes and circulating recombinant forms (CRFs) in Northern Greece
534
HIV-1 subtypes and male-to-female transmission in Thailand
535
HIV-1 subtypes in different risk groups in South Africa
536
HIV-1 suppression by early treatment with hydroxyurea, didanosine, and a protease inhibitor
537
HIV-1 suppression during acute scrub-typhus infection
538
HIV-1 Tat increases the adhesion of monocytes and T-cells to the endothelium in vitro and in vivo: implications for AIDS-associated vasculopathy
539
HIV-1 Tat interaction with cyclin T1 represses mannose receptor and the bone morphogenetic protein receptor-2 transcription
540
HIV-1 Tat Protects CD4+ Jurkat T Lymphoblastoid Cells from Apoptosis Mediated by TNF-Related Apoptosis-Inducing Ligand
541
HIV-1 Tat Protein and Its Inhibitor Ro 24-7429 Inhibit Lymphocyte Proliferation and Induce Apoptosis in Peripheral Blood Mononuclear Cells from Healthy Donors
542
HIV-1 Tat protein induces IL-10 production by an alternative TNF-α-independent pathway in monocytes: Role of PKC-δ and p38 MAP kinase
543
HIV-1 Tat protein induces TNF-α and IL-10 production by human macrophages: Differential implication of PKC-βII and -δ isozymes and MAP kinases ERK1/2 and p38
544
HIV-1 Tat vaccines
545
HIV-1 Tat: coping with negative elongation factors
546
HIV-1 Tat-mediated protein transduction of Cu,Zn-superoxide dismutase into pancreatic β cells in vitro and in vivo
547
HIV-1 therapy and fetal mitochondrial dysfunction
548
HIV-1 trans-Activating (Tat) Protein BOTH A TARGET AND A TOOL IN THERAPEUTIC APPROACHES
549
HIV-1 Transcription: Activation Mediated by Acetylation of Tat
550
HIV-1 transforms the monocyte plasma membrane proteome
551
HIV-1 transmission during scintigraphy
552
HIV-1 transmission through artificial insemination
553
HIV-1 transport across the blood–brain barrier is enhanced by lipopolysaccharide
554
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
555
HIV-1 vaccines and the nef story so far
556
HIV-1 viral load and scrub typhus
557
HIV-1 viral load and scrub typhus
558
HIV-1 viral load and scrub typhus
559
HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial
560
HIV-1 Viral RNA Is Selected in the Form of Monomers that Dimerize in a Three-step Protease-dependent Process; the DIS of Stem–Loop 1 Initiates Viral RNA Dimerization
561
HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific
562
HIV-1, antiretroviral therapy, and malaria
563
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
564
HIV-1, the brain, and combination therapy
565
HIV-1/AIDS and maternal and child health in Africa
566
HIV-1/AIDS and the control of other infectious diseases in Africa
567
HIV-1: hitching a ride on erythrocytes
568
HIV-1-associated nephropathy and response to highly-active antiretroviral therapy
569
HIV-1c vaccine trial planned for South Africa
570
HIV-1-mediated syncytium formation promotes cell-to-cell transfer of Tax protein and HTLV-I gene expression
571
HIV-1-resistance mechanisms continue to unravel
572
HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene
573
HIV-1-resistant individuals may lack HIV-1 coreceptor
574
HIV-1-vaccine-trial go-ahead reawakens ethics debate
575
HIV-2 and T cell recognition
576
HIV-associated adipose redistribution syndrome as a selective autonomic neuropathy
577
HIV-associated cardiovascular complications: a new challenge for emergency physicians
578
HIV-associated diarrhoea and wasting
579
HIV-associated diarrhoea and wasting : Report of a meeting at the University of Texas Medical School at Houston
580
HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation
581
HIV-Associated Nephropathy in the Era of Antiretroviral Therapy
582
HIV-associated respiratory disease
583
HIV-associated respiratory disease
584
HIV-associated respiratory disease
585
HIV-associated respiratory diseases
586
HIV-contamination scare adds to US gene researchersʹ woes
587
HIV-Derived Lentiviral Vectors: Current Progress toward Gene Therapy and DNA Vaccination
588
Hive: distributed agents for networking things
589
HIVE: Helping Interdisciplinary Vocabulary Engineering
590
HIV-Encephalopathy as initial manifestation of acquired immunodeficiency Syndrome in Yucatلn State, Mexico
591
HIV-I TAT Inhibits PKR Activity by Both RNA-Dependent and RNA-Independent Mechanisms
592
HIV-Induced Syncytia in Peripheral Blood Cell Cultures Crawl by Extending Giant Pseudopods
593
HIV-infected healthcare workers: results from a straw poll
594
HIV-infected women in ART programmes
595
HIV-infected women: Barriers to AZT use
596
HIV-integrase aptamer folds into a parallel quadruplex: A thermodynamic study Original Research Article
597
HIV-l and the microRNA-guided silencing pathway: An intricate and multifaceted encounter
598
HIV-negative patient with HHV-8 DNA follicular B-cell lymphoma associated with Kaposiʹs sarcoma
599
HIVNET nevirapine trials
600
HIVNET nevirapine trials
601
HIVNET nevirapine trials
602
HIVNET nevirapine trials
603
HIVNET nevirapine trials
604
HIV-positive mothers in Uganda resort to breastfeeding
605
HIV-Positive Patients: Dental Management Considerations
606
HIV-positive people, risk and sexual behaviour
607
HIV-positive servicemen in USA face discharge
608
HIV-prevention strategies
609
HIV-prevention strategies
610
HIV-related lipodystrophy and facial lipoatrophy: The role of Restylane SubQ in reversing facial wasting
611
HIV-related lipodystrophy and related factors
612
HIV-related oral disease
613
HIV-Related Oral Lesions, Demographic Factors, Clinical Staging and Anti-Retroviral Use
614
HIV-related sexual behaviour among migrants and non-migrants in a rural area of China: Role of rural-to-urban migration
615
HIV-related sexual risk assessment among Asian/Pacific Islander American Women: an inductive model
616
HIV-related skin diseases
617
HIV-related skin diseases
618
HIV-related skin diseases
619
HIV-related skin diseases
620
HIV-Related Stigma Among Healthcare Providers in Different Healthcare Settings: A Cross-Sectional Study in Kerman, Iran
621
HIV-related stigma: Adapting a theoretical framework for use in India
622
HIV-related thrombocytopenia
623
HIV-specific CD4+ T cells and viremia: whoʹs in control?
624
HIV-specific immunity in HIV-discordant heterosexual couples
625
HIV-vaccine research takes one step forward … and one step back
626
HIx concentration by electro-electrodialysis using stacked cells for thermochemical water-splitting IS process
627
HIx system thermodynamic model for hydrogen production by the Sulfur–Iodine cycle
628
Hiyama coupling reaction of fluorous alkenyl-fluorosilanes: Scope and mechanistic considerations
629
Hiyama reaction of aryl bromides with arylsiloxanes catalyzed by a reusable palladium(II)/cationic bipyridyl system in water
630
HJA (1921–2008)
631
Hjálmar Vilhjálmsson (September 25, 1937–August 20, 2011)
632
Hjelmslev planes over nearrings Original Research Article
633
Hjørlandʹs critique of batesʹ work on defining information
634
HJURP Is a Cell-Cycle-Dependent Maintenance and Deposition Factor of CENP-A at Centromeres
635
HJWFTAC: software for Hantush–Jacob analysis of variable-rate, multiple-extraction well pumping tests
636
HK97 Maturation Studied by Crystallography and H/2H Exchange Reveals the Structural Basis for Exothermic Particle Transitions
637
HKR theorem for smooth S-algebras
638
HKT and OKT geometries on soliton black hole moduli spaces Original Research Article
639
HKT geometry and de Sitter supergravity Original Research Article
640
HKUST-1 as an efficient and reusable heterogeneous catalyst for synthesis of 1,4-dihydropyridine at room temperature
641
HL 752: A potent and long-acting antispasmodic agent Original Research Article
642
HL Aurigae: A pre-contact binary system with a solar-mass companion
643
H–L curve: A novel 2D graphical representation for DNA sequences
644
HL-2A control system and its discharge management
645
HL-60 cells degrade α-actinin to produce a fragment that promotes monocyte/macrophage maturation
646
HL7 Messaging Engine with Customizable Translation System
647
HLA and AIDS: a cautionary tale
648
HLA and autoimmune diseases: Type 1 diabetes (T1D) as an example
649
HLA and inflammatory bowel disease
650
HLA and KIR polymorphisms affect NK-cell anti-tumor activity
651
HLA and natural history of HIV infection
652
HLA AND RISK OF ACUTE GRAFT VERSUS HOST DISEASE IN ALLOGENEIC BONE MARROW TRANSPLANTATION FROM AN HLA-IDENTICAL SIBLING
653
HLA antigen frequencies in end-stage idiopathic and ischaemic cardiomyopathy
654
HLA antigens in an Omani population with dilated cardiomyopathy
655
HLA antigens in patients with interferon-α-induced autoimmune thyroid disorders in chronic hepatitis C
656
HLA antigens in patients with variant angina in Japan
657
HLA antigens in schizophrenia and mood disorders
658
HLA association with autoimmune disease: restricted binding or T-cell selection?
659
HLA associations in type 1 diabetes: merging genetics and immunology
660
HLA B44 is associated with decreased severity of autoimmune lymphoproliferative syndrome in patients with CD95 defects (ALPS type Ia)
661
HLA based architecture for molecular communication simulation
662
HLA Class I Allele Frequencies in Southern Iranian Women with Breast Cancer
663
HLA Class I and Class II Genes Distribution of the Sistanis in Iran
664
HLA class I and II polymorphisms in Mexican Mestizo patients with dengue fever
665
HLA class I antigen expression in malignant cells: why does it not always correlate with CTL-mediated lysis?
666
HLA Class I Expression on Human Ovarian Carcinoma Cells Correlates with T-Cell Infiltrationin Vivoand T-Cell Expansionin Vitroin Low Concentrations of Recombinant Interleukin-2
667
HLA Class I Gene Polymorphism in Iranian Patients with Papillon-Lefevre Syndrome
668
HLA class I specific inhibitory receptors
669
HLA class I, II & III genes in confirmed late-onset Alzheimer’s disease
670
HLA Class II Allele and Haplotype Frequencies in Iranian Patients with Acute Myelogenous Leukemia and Control Group
671
HLA Class II Allele and Haplotype Frequencies in Iranian Patients with Leukemia
672
HLA class II alleles and genetic predisposition to the antiphospholipid syndrome
673
HLA class II and antibody responses to circumsporozoite protein repeats of P. vivax (VK210, VK247 and P. vivax-like) in individuals naturally exposed to malaria
674
HLA class II and autoimmunity: Epitope selection vs differential expression
675
HLA class II association with autoimmune hepatitis in Latin America: A meta-analysis
676
HLA class II DNA typing in Buergerʹs disease
677
HLA class II favors clearance of HCV infection and progression of the chronic liver damage
678
HLA class II Genetic Diversity in Arabs and Jews of Iran
679
HLA class II genotype, HLA-DR B cell surface expression and allergen specific IgE production in atopic and non-atopic members of asthmatic family pedigrees
680
HLA class II homozygosity confers susceptibility to common variable immunodeficiency (CVID)
681
HLA Class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis
682
HLA class II involvement in HIV-associated Toxoplasmic encephalitis development
683
HLA Class II Molecule Signal Transduction Leads to either Apoptosis or Activation via Two Different Pathways
684
HLA class II polymorphism in Latin American patients with multiple sclerosis
685
HLA Class I-Restricted and Tumor-Specific Cytotoxic T Lymphocytes from Metastatic Lymph Nodes of Esophageal Cancers
686
HLA DR11 and DR12 in chronic hepatitis C: reply to Zavaglia et al.
687
HLA DRB5*01 Association Survey with Multiple Sclerosis in Khuzestan Province of Iran
688
HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cells
689
HLA genomics in the third millennium
690
HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload
691
HLA in breast cancer: its relevance for immunotherapy
692
HLA in French patients with variant Creutzfeldt-Jakob disease
693
HLA matching and outcome of heart transplantation
694
HLA MATCHMAKER: A MOLECULARLY BASED ALGORITHM FOR HISTOCOMPATIBILITY DETERMINATION
695
HLA PROFILE AND CLINICAL PRESENTATION OF MULTIPLE SCLEROSIS IN IRAN
696
HLA specificity and kidney transplantation
697
HLA supertypes and supermotifs: a functional perspective on HLA polymorphism
698
HLA tetramer-based artificial antigen-presenting cells for stimulation of CD4+ T cells
699
HLA typing from Serology to Sequencing Era
700
HLA typing in chronic type B, D and C hepatitis
701
HLA typing in Taiwanese patients with oral squamous cell carcinoma
702
HLA_ACTOR_REPAST: An approach to distributing RePast models for high-performance simulations
703
HLA-A and CTGB33 polymorphisms and variation in IQ scores
704
HLA-A Locus-Restricted and Tumor-Specific CTLs in Tumor-Infiltrating Lymphocytes of Patients with Non-Small Cell Lung Cancer
705
HLA-A*26 and Susceptibility of Iranian Patients with Non-Hodgkin Lymphoma
706
HLA-A, B, C, DR and DQ expression and hepatocellular carcinoma: study of 205 Italian subjects
707
HLA-A2.1/Kb Transgenic Murine Dendritic Cells Transduced with an Adenovirus Encoding Human gp100 Process the Same A2.1-Restricted Peptide Epitopes as Human Antigen-Presenting Cells and Elicit A2.1-Restricted Peptide-Specific CTL
708
HLA-B*1502 in Iranian Children with Anticonvulsant Drugs-Induced Skin Reactions
709
HLA-B27 and Ankylosing Spondylitis geographic distribution as the result of a genetic selection induced by malaria endemic? A review supporting the hypothesis
710
HLA-B27 Association with Uveitis in an Asian Indian Population
711
HLA-B27 binding of peptide from its own sequence and similar peptides from bacteria: implications for spondyloarthropathies
712
HLA-B27 Subtypes Differentially Associated with Disease Exhibit Conformational Differences in Solution
713
HLA-B51 IN BEHÇET’S DISEASE
714
HLA-Class II in Latin American patients with type 1 diabetes
715
HLA-Cw Allele Frequency in Definite Meniere’s Disease Compared to Probable Meniere’s Disease and Healthy Controls in an Iranian Sample
716
HLA-DM and the MHC Class II Antigen Presentation Pathway
717
HLA-DM, HLA-DO and tapasin: functional similarities and differences
718
HLA-DMB expression by thyrocytes: indication of thé antigen-processing and possible presenting capability of thyroid cells
719
HLA-DQ Genotypes in Classic Type 1 Diabetes and in Latent Autoimmune Diabetes of the Adult
720
HLA-DQ8 is a predisposing molecule for detergent enzyme subtilisin BPN′-induced hypersensitivity
721
HLA-DR expression and lymphocytic infiltration in metastatic and non-metastatic papillary carcinoma of the thyroid
722
HLA-DR Polymorphism and Primary Biliary Cirrhosis: Evidence From a Meta-analysis
723
HLA-DR Typing by Polymerase Chain Reaction with Sequence- Specific Primers Compared to Serological typing
724
HLA-DR, ICAM-1, CD40, CD40L, and CD86 are incorporated to a similar degree into clinical human immunodeficiency virus type 1 variants expanded in natural reservoirs such as peripheral blood mononuclear cells and human lymphoid tissue cultured ex vivo
725
HLA-DR/DQ associations with rheumatic heart disease (RHD) in Mexicans
726
HLA-DRB and HLA-DQB Allele and Haplotype Frequencies in Iranian Patients with Recurrent Aphthous Stomatitis
727
HLA-DRB and HLA-DQB loci in the genetic uceptibility to develop glaucoma in Mexican Original Reearch Article
728
HLA‑DRB1 gene polymorphisms in Iranian children with Henoch‑Schönlein purpura
729
HLA-DRB1 leprogenic motifs in Nigerian population groups
730
HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis
731
HLA-DRB1*1301 AND *1302 protect against chronic hepatitis B
732
HLA-DRB1, DQA1 and DQB1 Alleles and Haplotypes Frequencies in Iranian Healthy Adult Responders and Non-Responders to Recombinant Hepatitis B Vaccine
733
HLA-DRβ1, Circulating Th1/Th2 Cytokines and Immunological Homunculus in Coronary Atherosclerosis
734
HLA-DRβ1, Circulating Th1/Th2 Cytokines and Immunological Homunculus in Coronary Atherosclerosis
735
HLA-DR1, Circulating Th1/Th2 Cytokines and Immunological Homunculus in Coronary Atherosclerosis
736
HLA-G allele and haplotype frequencies in a healthy population of Iran.
737
HLA-G and MIC expression in tumors and their role in anti-tumor immunity
738
HLA-G expression in trophoblast cells circulating in maternal peripheral blood during early pregnancy
739
HLA-G Expression Pattern: Reliable Assessment for Pregnancy Outcome Prediction
740
HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia
741
HLA-G remains a mystery
742
HLA-G*0105N Null Allele Encodes Functional HLA-G Isoforms
743
HLA-G: a shield against inflammatory aggression
744
HLA-G: Facts and Fictions
745
HLA-G: from biology to clinical benefits
746
HLA-G1 increases the radiosensitivity of human tumoral cells
747
HLA-G5 and G7 Isoforms in Pregnant Women
748
HLA-H Mutations in the Ashkenazi Jewish Population
749
HLA-Ig-based artificial antigen-presenting cells: setting the terms of engagement
750
HLA-KIR Interactions and Immunity to Viral Infections
751
HLA-peptide tetrameric complexes
752
Hِlder conjugacies for random dynamical systems
753
Hِlder Exponent for a Two-Parameter Lévy Process
754
Hِlder regularity for non-divergence-form elliptic equations with discontinuous coefficients
755
Hِlder regularity for operator scaling stable random fields
756
Hِlder regularity for the gradients of solutions of the strong -Laplacian
757
Hِlder regularity for weak solutions to divergence form degenerate quasilinear parabolic systems
758
Hِlder type inequality for Sugeno integral
759
Hِlderian variational problems subject to integral constraints
760
HLHS With Severe Aortic Insufficiency in a Patient With 45,X/46,XY Mosaicism
761
HLI, A Direct Method Suitable for Partial and Fully Implicit Time Integration of Primitive Equation Meteorological Models
762
H-lifts of tangential k-blocks Original Research Article
763
HLLC solver for ideal relativistic MHD
764
HLLC-type Riemann solver for the Baer–Nunziato equations of compressible two-phase flow
765
HlLgm2, a member of asparaginyl endopeptidases/legumains in the midgut of the ixodid tick Haemaphysalis longicornis, is involved in blood-meal digestion
766
HLS RF cavity development in NSRL phase II project
767
HLS RF cavity development in NSRL phase II project
768
HLW glass dissolution in the presence of magnesium carbonate: Diffusion cell experiment and coupled modeling of diffusion and geochemical interactions
769
HMAC: An Enhanced Energy Efficient Protocol Design for Control Applications Using WSNS
770
HMAC-Based Authentication Protocol: Attacks and Improvements
771
HMB and Cp* ruthenium(II) complexes containing bis- and tris-(mercaptomethimazolyl)borate ligands: Synthetic, X-ray structural and electrochemical studies (HMB = η6-C6Me6, Cp* = η5-C5Me5)
772
HMB-45 Study Before and After Narrow-Band (311 nm) Ultraviolet B Treatment in Vitiligo
773
HMB-45 Study Before and After Narrow-Band (311 nm) Ultraviolet B Treatment in Vitiligo
774
HMB-45 Study Before and After Narrow-Band (311 nm) Ultraviolet B Treatment in Vitiligo
775
HMB-45 Study Before and After Narrow-Band (311 nm) Ultraviolet B Treatment in Vitiligo
776
HMB-45 Study Before and After Narrow-Band (311 nm) Ultraviolet B Treatment in Vitiligo
777
HMC algorithm with multiple time scale integration and mass preconditioning Original Research Article
778
H-measures and variants applied to parabolic equations
779
HMF sectors since 1926: Comparison of two ground-based data sets Original Research Article
780
HMG CoA reductase inhibitor (statin) and aortic valve calcium
781
HMG CoA reductase inhibitors are related to improved systemic endothelial function in coronary artery disease
782
HMGA2 expression in a canine model of prostate cancer
783
HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity
784
HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression
785
HMGA2 is expressed in an allele-specific manner in human lipomas
786
HMGA2 overexpression in polycythemia vera with t(12;21)(q14;q22)
787
Hmga2 Promotes Neural Stem Cell Self-Renewal in Young but Not Old Mice by Reducing p16Ink4a and p19Arf Expression
788
HMGA2, MicroRNAs, and Stem Cell Aging
789
HMGA2–NFIB fusion in a pediatric intramuscular lipoma: a novel case of NFIB alteration in a large deep-seated adipocytic tumor
790
HMGA-targeted phosphorothioate DNA aptamers increase sensitivity to gemcitabine chemotherapy in human pancreatic cancer cell lines
791
HMGB Binding to DNA: Single and Double Box Motifs
792
HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques
793
HMGB-1 induces cell motility and α5β1 integrin expression in human chondrosarcoma cells
794
HMGB1: a two-headed signal regulating tumor progression and immunity
795
HMGB1: guiding immunity from within
796
HMGB1-stimulated human primary cardiac fibroblasts exert a paracrine action on human and murine cardiac stem cells
797
HMGB2 stabilizes p53 by interfering with E6/E6AP-mediated p53 degradation in human papillomavirus-positive HeLa cells
798
HMG-Co reductase inhibition by atorvastatin reduces neointimal inflammation in rabbit model of atherosclerosis
799
HMG-Co Reductase Inhibitors Decrease CD11b Expression and CD11b-Dependent Adhesion of Monocytes to Endothelium and Reduce Increased Adhesiveness of Monocytes Isolated From Patients With Hypercholesterolemi
800
HMG-Co reductase inhibitors reduce cerebral infarct size by upregulating endothelial nitric oxide synthase
801
HMG-CoA inhibitors induced the LDL oxidation
802
HMG-CoA reductase and ACAT inhibitors act synergistically to lower plasma cholesterol and limit atherosclerotic lesion development in the cholesterol-fed rabbit Original Research Article
803
HMG-CoA reductase inhibition improves anti-aging klotho protein expression and arteriosclerosis in rats with chronic inhibition of nitric oxide synthesis
804
HMG-CoA reductase inhibition improves endothelial cell function and inhibits smooth muscle cell proliferation in human saphenous veins  
805
HMG-CoA reductase inhibitor enhances inducible nitric oxide synthase expression in rat vascular smooth muscle cells; involvement of the Rho/Rho kinase pathway
806
HMG-CoA reductase inhibitor improves endothelial dysfunction in mineralocorticoid hypertension by inhibition of RhoA
807
HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data Original Research Article
808
HMG-CoA reductase inhibitors induce apoptosis in neointima-derived vascular smooth muscle cells
809
HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levels
810
HMG-CoA reductase inhibitors suppress macrophage growth induced by oxidized low density lipoprotein
811
HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis
812
HMG-CoA reductase inhibitors, gemfibrozil, and myopathy
813
HMGIC alterations in smooth muscle tumors of soft tissues and other sites
814
HMGI-C and HMGI(Y) expression in uterine leiomyomata: dysregulation of architectural factors in a benign neoplasm
815
HMGIC Expressed in a Uterine Leiomyoma with a Deletion of the Long Arm of Chromosome 7 Along with a 12q14–15 Rearrangement But Not in Tumors Showing del(7) as the Sole Cytogenetic Abnormality
816
HMM delay prediction technique for VoIP
817
HMM topology design using maximum likelihood successive state splitting
818
HMM-Based Gain Modeling for Enhancement of Speech in Noise
819
HMM-based handwritten word recognition: on the optimization of the number of states, training iterations and Gaussian components
820
HMM-based on-line signature verification: Feature extraction and signature modeling
821
HMM-based strategies for enhancement of speech signals embedded in nonstationary noise
822
HMM-based stressed speech modeling with application to improved synthesis and recognition of isolated speech under stress
823
Hmmmm Gardening Some Comments on Garden Style and False Economy
824
HMM-separation-based speech recognition for a distant moving speaker
825
HMMSTR: a hidden Markov model for local sequence-structure correlations in proteins
826
HMO formularies and care costs
827
HMO formularies and care costs
828
HMO formularies lead to higher care costs
829
HMO penetration and the geographic mobility of practicing physicians
830
HMO physiciansʹ use of referrals
831
HMO stocks hit bad times, say analysts
832
H-mode barrier control with external magnetic perturbations
833
H-module endomorphism rings Original Research Article
834
H-mordenite zeolite as an efficient, rapid and recyclable catalyst for chemoselective synthesis of 1,1-diacetates under solvent-free conditions
835
H-Morph: an indirect approach to advancing front hex meshing
836
HMOs, market competition, and premium cost
837
HMOs, moral hazard and cost shifting in workersʹ compensation
838
HMPAO-SPECT imaging during intense Tibetan Buddhist meditation
839
HMS SCOTT ring laser gyro navigator integration
840
HMT assisted hydrothermal synthesis of various ZnO nanostructures: Structure, growth and gas sensor properties
841
HMT production and sublimation during thermal process of cometary organic analogs. Implications for its detection with the ROSETTA instruments
842
HMTTEF.C60-A 2-D close-packed layered compound of C60
843
h-Multigrid for space-time discontinuous Galerkin discretizations of the compressible Navier–Stokes equations
844
hMutSα is Protected from Ubiquitin-proteasome-dependent Degradation by Atypical Protein Kinase Cζ Phosphorylation
845
hMutSα is Protected from Ubiquitin-proteasome-dependent Degradation by Atypical Protein Kinase Cζ Phosphorylation Original Research Article
846
HMW1555-914, HMW2553-916, and Hia585-705 as Subunit Vaccine Candidates of Nontypeable Haemophilus influenzae Induce Specific Antibody Responses with Bactericidal Activity in Balb/c
847
HMX decomposition model to characterize thermal damage
848
HNE increases HO-1 through activation of the ERK pathway in pulmonary epithelial cells
849
HNF/HTPB propellants: Influence of HNF particle size on ballistic properties
850
HNF-1 alpha: have bile acid transport genes found their “master”?
851
HNF4α Antagonists Discovered by a High-Throughput Screen for Modulators of the Human Insulin Promoter Original Research Article
852
HNF-4α: from MODY to late-onset type 2 diabetes
853
HNN extensions of inverse semigroups and groupoids
854
HNN extensions of von Neumann algebras
855
HNN-Extensions of Finitely Presented Soluble Groups Original Research Article
856
HNN-Extensions of Finitely Presented Soluble Groups Original Research Article
857
HNO made-easy from photochemical cycloreversion of novel 3,5-heterocyclic disubstituted 1,2,4-oxadiazole-4-oxides
858
HNO3 analyzer by scrubber difference and the NO–ozone chemiluminescence method
859
HNO3 fluxes to a deciduous forest derived using gradient and REA methods
860
HNO3 losses within the cyclone inlet of a diffusion-denuder system under simulated marine environments
861
HNO3/H3PO4–NANO2 mediated oxidation of cellulose — preparation and characterization of bioabsorbable oxidized celluloses in high yields and with different levels of oxidation
862
HNO3/N,N-Diethylethanaminium-2-(Sulfooxy)Ethyl Sulfate as an Efficient System for the Regioselective of Aromatic Compounds
863
HNPCC mutations in hMSH2 result in reduced hMSH2-hMSH6 molecular switch functions
864
hnRNP K: An HDM2 Target and Transcriptional Coactivator of p53 in Response to DNA Damage
865
H-NS Oligomerization Domain Structure Reveals the Mechanism for High Order Self-association of the Intact Protein
866
hNηN final-state interaction in incoherent photoproduction of hη -mesons from the deuteron
867
HO in pregnancy,
868
H–O, S and Pb isotope geochemistry of the Awanda gold deposit in southern Tianshan, Central Asian orogenic belt: Implications for fluid regime and metallogeny
869
HO∴OH−: a model for stable three-electron bonded peroxide radical anions
870
HO-1 and VGEF gene expression in human arteries with advanced atherosclerosis
871
HO-1 induction attenuates renal damage and oxidative stress induced by K2Cr2O7
872
HO-1 pharmacological over-expression in a rat model of Type II diabetes: implications for microvascular tone and the genesis of ischemia
873
Ho3+ carbon paste sensor based on multi-walled carbon nanotubes: Applied for determination of holmium content in biological and environmental samples
874
Ho3+ sensitized upconverted emission from Er3+ doped TeO2 glass system
875
Ho3+: (5S2,5F4)→5I5 transition in fluoride glasses
876
Hoàng–Reed conjecture holds for tournaments
877
Hoarding and its relation to obsessive–compulsive disorder
878
Hoarding behaviors in a large college sample
879
Hoarding habitat selection of squirrels (Sciurus vulgaris) in Liangshui Nature Reserve, China
880
Hoarding in a compulsive buying sample
881
Hoarding in obsessive compulsive disorder: results from a case-control study
882
Hoarding in obsessive–compulsive disorder: Results from the OCD Collaborative Genetics Study
883
Hoarding, compulsive buying and reasons for saving
884
Hoarse cry: a sign of dehydration
885
Hoarseness after cardiac operations: Vocal cord paralysis or a conversion disorder?
886
Hoarseness as a Sign of Possible Nonspecific Mucosal Hyperreactivity in Vocal Tract
887
Hoarseness as Presenting Complain of a Glomus Vagale
888
HOARSENESS AS PRESENTING SYMPTOM OF PEDIATRIC LARYNGEAL AMYLOIDOSIS
889
Hoarseness as the Presenting Symptom of Visceral Leishmaniasis with Muco-Cutaneous Lesions: A Case Report.
890
Hoarseness Due to Bamboo Nodes in Patients with Autoimmune Diseases: A Review of Literature
891
Hob: a New Tool for Tracking and IncreasingValueAdded
892
Hobbes and Hume in relation to Kant
893
Hobbits, Hogwarts, and the Heavens: The use of fantasy literature and film in astronomy outreach and education
894
Hobbs Coast Cenozoic volcanism: Implications for the West Antarctic rift system
895
Hobbsʹ Food Poisoning and Food Hygiene, 7th edition, Jim McLauchlin, Christine Little (Eds.). Hudder Arnold (2007)
896
Hobbs’ Food Poisoning and Food Hygiene. 7th Edition, Edited by Jim McLaughlin and Christine Little, Hodder Arnold, 2007, ISBN: 978 034 090 5302 (PB), Price £19. 99
897
Hobermanʹs Sphere, Euler Parameters and Lagrangeʹs Equations
898
Hobomok, A Tale of Early Times as a Lieu de Memoire: Revising the Image of the Puritans and the History of Early New England
899
HOBt and HOAt-derived immonium salts: new and highly efficient coupling reagents for peptide synthesis
900
Hochschild (2003) — The managed heart: The recognition of emotional labour in public service work
901
HOCHSCHILD (CO)HOMOLOGY DIMENSION
902
Hochschild (Co)Homology of Differential Operator Rings,
903
Hochschild and cyclic homology of the quantum multiparametric torus Original Research Article
904
Hochschild cohomology and “smoothness” in monoidal categories
905
Hochschild cohomology and derived Picard groups
906
Hochschild cohomology and Linckelmann cohomology for blocks of finite groups
907
Hochschild Cohomology and the Coradical Filtration of Pointed Coalgebras: Applications
908
Hochschild cohomology is topological
909
Hochschild cohomology of abelian categories and ringed spaces
910
Hochschild cohomology of incidence algebras as one-point extensions Original Research Article
911
Hochschild Cohomology of Minimal Hereditary Orders Original Research Article
912
Hochschild Cohomology of Minimal Hereditary Orders Original Research Article
913
Hochschild cohomology of quasiprojective schemes Original Research Article
914
Hochschild cohomology of tame blocks
915
Hochschild Cohomology of Triangular Matrix Algebras,
916
Hochschild cohomology on Hopf Galois extensions Original Research Article
917
Hochschild duality, localization, and smash products
918
Hochschild homology and cohomology of some classical and quantum noncommutative polynomial algebras
919
Hochschild–Mitchell cohomology and Galois extensions
920
Hochschild-Serre spectral sequences of split extensions and cohomology of some extra-special p-groups Original Research Article
921
Hochstadt–Lieberman theorem for Dirac operator with eigenparameter dependent boundary conditions Original Research Article
922
Hockling behaviour of single- and multiple-rope systems
923
HOCl-mediated cell death and metabolic dysfunction in the yeast Saccharomyces cerevisiae
924
HOCl-modified phosphatidylcholines induce apoptosis and redox imbalance in HUVEC-ST cells
925
Hodar - inline holography applied to raindrop and snowflake in situ measurements
926
Hodge decomposition and conservation laws Original Research Article
927
Hodge decomposition to solve singular static Maxwellʹs equations in a non-convex polygon
928
Hodge decomposition with degenerate weights and the Gross–Pitaevskii energy
929
Hodge duality on the brane
930
Hodge theory on some invariant threefolds of even degree
931
Hodge-Helmholtz decompositions of weighted Sobolev spaces in irregular exterior domains with inhomogeneous and anisotropic media
932
Hodge-Laplace Operator on Compact Manifolds from Which a Finite Number of Balls Is Omitted
933
Hodges Lehmann Estimator for Robust Design Using Dual Response Surface Approach
934
Hodges–Lehmann optimality for testing moment conditions
935
Hodges–Lehmann optimality for testing moment conditions
936
Hodgetts+Fung
937
Hodgkinʹ cylinder
938
Hodgkin disease immunopathogenesis: long-standing questions, recent answers, further directions
939
Hodgkin Lymphoma and Anaplastic Variants of Non-Hodgkin Lymphoma
940
Hodgkin Lymphoma in adolescents
941
Hodgkin’s disease – new treatment strategies toward the cure of patients
942
Hodgkin’s disease presenting with a bronchoesophageal fistula
943
Hodgkin’s disease: biology and origin of Hodgkin and Reed-Sternberg cells
944
Hodgkin’s Lymphoma Presenting with Myocardial Metastasis and Heart Failure
945
Hodgkin–Huxley type ion channel characterization: An improved method of voltage clamp experiment parameter estimation
946
Hodgkinʹs disease
947
Hodgkinʹs disease and Vietnam service
948
Hodgkinʹs disease: A quantitative evaluation by computed tomography of tumor burden
949
Hodgkinʹs disease: are you the type?
950
Hodgkinʹs lymphoma
951
Hodgkinʹs Lymphoma Presenting with Heart Failure
952
Hodgkinʹʹs Lymphoma with Cutaneous Involvement
953
Hodgkinʹs lymphoma: an obscure cause of cholestasis
954
HODIE finite difference schemes on generalized Shishkin meshes
955
Hodograph transformation methods in incompressible second grade fluid
956
Hodographs and normals of rational curves and surfaces Original Research Article
957
Hodograph-type transformations Original Research Article
958
Ho-doped BaTiO3: Polymorphism, phase equilibria and dielectric properties of BaTi1−xHoxO3−x/2: 0 ≤ x ≤ 0.17
959
Hoeffding bound based evolutionary algorithm for symbolic regression
960
Hoeffding bound based evolutionary algorithm for symbolic regression
961
Hoeffding’s inequality for supermartingales
962
Hoeffdingʹs inequality for uniformly ergodic Markov chains
963
Hoehnke and Hereditary Radical Class
964
HOFEM07 – International workshop on high-order finite element methods, 2007
965
Hoffman polynomials of nonnegative irreducible matrices and strongly connected digraphs
966
Hoffman’s “proof” of the possibility of spectrum inversion
967
Hoffman’s Error Bounds and Uniform Lipschitz Continuity of Best l -Approximations
968
Hoffman-type identities Original Research Article
969
Hofmann degradation kinetics of n-octylamine adsorbed on layered aluminosilicates prepared from apophyllite
970
Hofmann, S. G. (2012). An Introduction to Modern CBT: Psychological Solutions to Mental Health Problems Malden, MA: Wiley-Blackwell
971
Hofmeister anion effects on aqueous solutions of poly(ethylene oxide) studied by attenuated total reflectance FT-IR spectroscopy
972
Hofmeister anion effects on surfactant self-assembly and the formation of mesoporous solids
973
Hofmeister effect in thermal field-flow fractionation of colloidal aqueous dispersions
974
Hofmeister effect on enzymatic catalysis and colloidal structures
975
Hofmeister effects in cationic microemulsions
976
Hofmeister effects in colloid science and biology explained by dispersion forces: analytic results for the double layer interaction
977
Hofmeister effects in supramolecular and biological systems Original Research Article
978
Hofmeister effects: Why protein charge, pH titration and protein precipitation depend on the choice of background salt solution
979
Hofmeister series and specific interactions of charged headgroups with aqueous ions
980
Hofmeister specific ion effects in two biological systems
981
Hofstadter spectrum in electric and magnetic fields
982
Hofstede never studied culture
983
Hofstede, Schwartz, or managerial perceptions? The effects of different cultural distance measures on establishment mode choices by multinational enterprises
984
HOG MAP kinase regulation of alternariol biosynthesis in Alternaria alternata is important for substrate colonization
985
Hog Producer Preferences for Marketing Contract Attributes
986
Högbomite in migmatitic paragneiss in the Betroka shear belt, Vohidava area, Precambrian of southern Madagascar
987
hOGG1 exon7 polymorphism and gastric cancer in case–control studies of Japanese Brazilians and non-Japanese Brazilians
988
Hohlraum targets driven by cluster ion beams for inertial confinement fusion
989
Hohlraum targets driven by cluster ion beams for inertial confinement fusion
990
Hohokam and Patayan interaction in southwestern Arizona: evidence from ceramic compositional analyses
991
Hoiamide A, a Sodium Channel Activator of Unusual Architecture from a Consortium of Two Papua New Guinea Cyanobacteria
992
Hoiamide A, a Sodium Channel Activator of Unusual Architecture from a Consortium of Two Papua New Guinea Cyanobacteria Original Research Article
993
Hoist on your own petard: When prejudiced remarks are recognized and backfire on speakers
994
Hoisting "Y" Columns at the Phoenix Airport Parking Garage Expansion
995
Hoja de perejilʹ (parsley leaf) of tomato and morrenia little leaf, two new diseases associated with a phytoplasma in Bolivia
996
Ho–Kashyap classifier with early stopping for regularization
997
Ho–Kashyap classifier with generalization control
998
HokieFlincs_H2O-NaCl: A Microsoft Excel spreadsheet for interpreting microthermometric data from fluid inclusions based on the PVTX properties of H2O–NaCl
999
Holarchy formation and optimization in holonic manufacturing systems with contract net
1000
Hold everything! Holding policies for protecting plasma supplies
بازگشت